Adocia Logo

Adocia

ADOC | PA

Overview

Corporate Details

ISIN(s):
FR0011184241 (+1 more)
LEI:
969500ZL79KYH9PTYP78
Country:
France
Address:
115 AVENUE LACASSAGNE, 69003 LYON
Sector:
Health Care
Industry:
Biotechnology

Description

Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. In the diabetes field, Adocia’s portfolio of injectable treatments is among the largest and most differentiated of the industry, featuring five clinical-stage products. Additionally, Adocia aims to expand its portfolio towards the treatment of other metabolic diseases and their comorbidities. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and/or safety of therapeutic proteins while making them easier for patients to use. Adocia customizes BioChaperone to each protein for a given application.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-12 18:00
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
English 492.1 KB
2025-06-12 18:00
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
French 491.7 KB
2025-05-22 18:00
Regulatory News Service
Inside Information / Other news releases
English 452.1 KB
2025-05-22 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 472.2 KB
2025-05-21 18:00
General Meeting Notice
Informations privilégiées / Autres communiqués
French 120.9 KB
2025-05-21 18:00
General Meeting Notice
Inside Information / Other news releases
English 130.5 KB
2025-05-15 18:00
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
English 474.1 KB
2025-05-15 18:00
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
French 473.1 KB
2025-05-14 18:00
Earnings Release
Inside Information / News release on accounts, results
English 576.9 KB
2025-05-14 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 531.5 KB
2025-04-30 18:00
Regulatory News Service
Inside Information / Other news releases
English 473.1 KB
2025-04-30 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 461.0 KB
2025-04-29 16:29
Annual Report (ESEF)
Document d'Enregistrement Universel 2024
French 3.6 MB
2025-04-28 18:00
Regulatory News Service
Inside Information / Other news releases
English 692.6 KB
2025-04-28 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 682.1 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2024-03-21 N/A Other Buy 51,921 499,999.23 EUR
2024-03-21 N/A Other Buy 15,576 149,996.88 EUR
2023-12-29 N/A Other Sell 20,000 236,550.00 EUR
2023-10-05 N/A Other Sell 50,000 400,000.00 EUR
2023-09-20 N/A Other Sell 36,240 291,376.85 EUR
2023-07-28 N/A Other Buy 220,264 999,998.56 EUR
2023-07-28 N/A Other Buy 110 499.40 EUR

Peer Companies

Company Country Ticker View
Atrys Health S.A. Logo Atrys Health S.A. Spain ATRY
AUKETT SWANKE GROUP PLC Logo AUKETT SWANKE GROUP PLC United Kingdom AUK
Azorean - Aquatic Technologies S.A. Logo Azorean - Aquatic Technologies S.A. Portugal MLAAT
Bachem Holding AG Logo Bachem Holding AG Switzerland BANB
Bavarian Nordic Logo Bavarian Nordic Denmark BAVA
BB Biotech AG Logo BB Biotech AG Switzerland BION
BEEKS FINANCIAL CLOUD GROUP PLC Logo BEEKS FINANCIAL CLOUD GROUP PLC United Kingdom BKS
BenevolentAI Logo BenevolentAI United Kingdom BAI
BerGenBio Logo BerGenBio Norway BGBIO
BIG Technologies PLC Logo BIG Technologies PLC United Kingdom BIG